CacheBy

Dimabio 제품 카탈로그

총 6,861개 제품 중 1,101–1,200번째 · 12 / 69 쪽. 파트넘버 순입니다. 제품을 열면 사양과 함께 재고·가격·납기를 문의할 수 있습니다.

  1. BME100594BBiotinylated Anti-CD19(obexelimab biosimilar) mAb
  2. BME100595Anti-TSLP(ocankitug biosimilar) mAb
  3. BME100595BBiotinylated Anti-TSLP(ocankitug biosimilar) mAb
  4. BME100596Anti-TIGIT(ociperlimab biosimilar) mAb
  5. BME100596BBiotinylated Anti-TIGIT(ociperlimab biosimilar) mAb
  6. BME100597Anti-CD20(ofatumumab biosimilar) mAb
  7. BME100597BBiotinylated Anti-CD20(ofatumumab biosimilar) mAb
  8. BME100598Anti-PDGFRA(olaratumab biosimilar) mAb
  9. BME100598BBiotinylated Anti-PDGFRA(olaratumab biosimilar) mAb
  10. BME100599Anti-VEGFR2(olinvacimab biosimilar) mAb
  11. BME100599BBiotinylated Anti-VEGFR2(olinvacimab biosimilar) mAb
  12. BME100600Anti-LGALS3(oloctinebart biosimilar) mAb
  13. BME100600BBiotinylated Anti-LGALS3(oloctinebart biosimilar) mAb
  14. BME100601Anti-IL6(olokizumab biosimilar) mAb
  15. BME100601BBiotinylated Anti-IL6(olokizumab biosimilar) mAb
  16. BME100602Anti-CLDN18.2(omectatug biosimilar) mAb
  17. BME100602BBiotinylated Anti-CLDN18.2(omectatug biosimilar) mAb
  18. BME100603Anti-C5(omoprubart biosimilar) mAb
  19. BME100603BBiotinylated Anti-C5(omoprubart biosimilar) mAb
  20. BME100604Anti-PCSK9(ongericimab biosimilar) mAb
  21. BME100604BBiotinylated Anti-PCSK9(ongericimab biosimilar) mAb
  22. BME100605Anti-CLDN18.2(osemitamab biosimilar) mAb
  23. BME100605BBiotinylated Anti-CLDN18.2(osemitamab biosimilar) mAb
  24. BME100606Anti-CD3E(otelixizumab biosimilar) mAb
  25. BME100606BBiotinylated Anti-CD3E(otelixizumab biosimilar) mAb
  26. BME100607Anti-IGHE(ozureprubart biosimilar) mAb
  27. BME100607BBiotinylated Anti-IGHE(ozureprubart biosimilar) mAb
  28. BME100608Anti-IL6(pacibekitug biosimilar) mAb
  29. BME100608BBiotinylated Anti-IL6(pacibekitug biosimilar) mAb
  30. BME100609Anti-PD-L1(pacmilimab biosimilar) mAb
  31. BME100609BBiotinylated Anti-PD-L1(pacmilimab biosimilar) mAb
  32. BME100610Anti-EGFR(panitumumab biosimilar) mAb
  33. BME100610BBiotinylated Anti-EGFR(panitumumab biosimilar) mAb
  34. BME100611Anti-TLR4(paridiprubart biosimilar) mAb
  35. BME100611BBiotinylated Anti-TLR4(paridiprubart biosimilar) mAb
  36. BME100612Anti-EDNRA(patecibart biosimilar) mAb
  37. BME100612BBiotinylated Anti-EDNRA(patecibart biosimilar) mAb
  38. BME100613Anti-PD-1(penpulimab biosimilar) mAb
  39. BME100613BBiotinylated Anti-PD-1(penpulimab biosimilar) mAb
  40. BME100614Anti-SEMA4D(pepinemab biosimilar) mAb
  41. BME100614BBiotinylated Anti-SEMA4D(pepinemab biosimilar) mAb
  42. BME100615Anti-PD-1(peresolimab biosimilar) mAb
  43. BME100615BBiotinylated Anti-PD-1(peresolimab biosimilar) mAb
  44. BME100616Anti-Her2(pertuzumab biosimilar) mAb
  45. BME100616BBiotinylated Anti-Her2(pertuzumab biosimilar) mAb
  46. BME100617Anti-IL23A(picankibart biosimilar) mAb
  47. BME100617BBiotinylated Anti-IL23A(picankibart biosimilar) mAb
  48. BME100618Anti-PD-1(pidilizumab biosimilar) mAb
  49. BME100618BBiotinylated Anti-PD-1(pidilizumab biosimilar) mAb
  50. BME100619Anti-PD-1(pimivalimab biosimilar) mAb
  51. BME100619BBiotinylated Anti-PD-1(pimivalimab biosimilar) mAb
  52. BME100620Anti-EGFR(pimurutamab biosimilar) mAb
  53. BME100620BBiotinylated Anti-EGFR(pimurutamab biosimilar) mAb
  54. BME100621Anti-CD123(pivekimab biosimilar) mAb
  55. BME100621BBiotinylated Anti-CD123(pivekimab biosimilar) mAb
  56. BME100622Anti-LILRB2(polzastobart biosimilar) mAb
  57. BME100622BBiotinylated Anti-LILRB2(polzastobart biosimilar) mAb
  58. BME100623Anti-MAPT(posdinemab biosimilar) mAb
  59. BME100623BBiotinylated Anti-MAPT(posdinemab biosimilar) mAb
  60. BME100624Anti-C5(pozelimab biosimilar) mAb
  61. BME100624BBiotinylated Anti-C5(pozelimab biosimilar) mAb
  62. BME100625Anti-PD-1(pradusinstobart biosimilar) mAb
  63. BME100625BBiotinylated Anti-PD-1(pradusinstobart biosimilar) mAb
  64. BME100626Anti-SNCA(prasinezumab biosimilar) mAb
  65. BME100626BBiotinylated Anti-SNCA(prasinezumab biosimilar) mAb
  66. BME100627Anti-CEACAM5(precemtabart biosimilar) mAb
  67. BME100627BBiotinylated Anti-CEACAM5(precemtabart biosimilar) mAb
  68. BME100628Anti-PD-1(prolgolimab biosimilar) mAb
  69. BME100628BBiotinylated Anti-PD-1(prolgolimab biosimilar) mAb
  70. BME100629Anti-PD-1(pucotenlimab biosimilar) mAb
  71. BME100629BBiotinylated Anti-PD-1(pucotenlimab biosimilar) mAb
  72. BME100630Anti-VEGFR2(pulocimab biosimilar) mAb
  73. BME100630BBiotinylated Anti-VEGFR2(pulocimab biosimilar) mAb
  74. BME100631Anti-B7-H4(puxitatug biosimilar) mAb
  75. BME100631BBiotinylated Anti-B7-H4(puxitatug biosimilar) mAb
  76. BME100632Anti-CTLA-4(quavonlimab biosimilar) mAb
  77. BME100632BBiotinylated Anti-CTLA-4(quavonlimab biosimilar) mAb
  78. BME100633BBiotinylated Anti-LIGHT(quisovalimab biosimilar) mAb
  79. BME100634Anti-IL4RA(rademikibart biosimilar) mAb
  80. BME100634BBiotinylated Anti-IL4RA(rademikibart biosimilar) mAb
  81. BME100635Anti-TIGIT(ralzapastotug biosimilar) mAb
  82. BME100635BBiotinylated Anti-TIGIT(ralzapastotug biosimilar) mAb
  83. BME100636Anti-CD40(ravagalimab biosimilar) mAb
  84. BME100636BBiotinylated Anti-CD40(ravagalimab biosimilar) mAb
  85. BME100637Anti-C5(ravulizumab biosimilar) mAb
  86. BME100637BBiotinylated Anti-C5(ravulizumab biosimilar) mAb
  87. BME100638Anti-PCSK9(recaticimab biosimilar) mAb
  88. BME100638BBiotinylated Anti-PCSK9(recaticimab biosimilar) mAb
  89. BME100639Anti-IL1RL2(recibokibart biosimilar) mAb
  90. BME100639BBiotinylated Anti-IL1RL2(recibokibart biosimilar) mAb
  91. BME100640Anti-VEGFB(reflocibart biosimilar) mAb
  92. BME100640BBiotinylated Anti-VEGFB(reflocibart biosimilar) mAb
  93. BME100641Anti-APP(remternetug biosimilar) mAb
  94. BME100641BBiotinylated Anti-APP(remternetug biosimilar) mAb
  95. BME100642Anti-PVRIG(remzistotug biosimilar) mAb
  96. BME100642BBiotinylated Anti-PVRIG(remzistotug biosimilar) mAb
  97. BME100643Anti-TIGIT(renvistobart biosimilar) mAb
  98. BME100643BBiotinylated Anti-TIGIT(renvistobart biosimilar) mAb
  99. BME100644Anti-IL5(reslizumab biosimilar) mAb
  100. BME100644BBiotinylated Anti-IL5(reslizumab biosimilar) mAb